[Prediction of the outcome of IFN therapy in type C chronic hepatitis from serological grouping of hepatitis C virus].
We investigated the relationship between serological grouping of hepatitis C virus and the response to IFN therapy in type C chronic hepatitis. In group I, responders were low (28%) with a high incidence of recurrence of HCV-RNA (72%). By contrast, in group II, responders were high (62%) and recurrence of HCV-RNA (17%) was low. Serological grouping of hepatitis C virus is useful in the prediction of the outcome of IFN therapy in type C chronic hepatitis.
Sakai
A
A
First Department of Internal Medicine, Kanazawa University School of Medicine.
Yanagi
M
M
Unoura
M
M
Kobayashi
K
K
D002908:Chronic Disease; D005838:Genotype; D016174:Hepacivirus / Q000145:classification* / Q000235:genetics; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D012008:Recurrence; D012703:Serotyping; D016896:Treatment Outcome
D012367:RNA, Viral; D007372:Interferons